Literature DB >> 21317650

Is worsening multiple organ failure the cause of death in patients with severe sepsis?

Jean-Louis Vincent1, David R Nelson, Mark D Williams.   

Abstract

OBJECTIVES: Although the mortality of severe sepsis is easily quantified, the actual cause and timing of death from severe sepsis are less defined. We used the INDEPTH (International Integrated Database for the Evaluation of Severe Sepsis and Drotrecogin alfa activated) database to investigate the reported cause of death in patients with severe sepsis.
DESIGN: Retrospective database analysis. PATIENTS: Data from 4459 patients with severe sepsis (drotrecogin alfa activated, n = 3228; placebo, n = 1231) included in five clinical trials conducted in tertiary care institutions in 28 countries.
MEASUREMENTS AND MAIN RESULTS: We examined the cause of death and the pattern of Sequential Organ Failure Assessment scores near the time of death. We also evaluated the time course of biomarker levels at this late stage. A total of 1201 (27.0%) patients died during the 28-day study period. The main causes of death were as follows: sepsis-associated multiple organ failure (43.1%), refractory septic shock (22.6%), and respiratory failure (13.0%). There were no significant differences in the distributions of cause of death between drotrecogin alfa activated and placebo patients, so that all patients were combined for analysis. The mean cardiovascular Sequential Organ Failure Assessment score increased from 2.4, 4 days before death, to 2.9, 1 day before death, and the mean respiratory Sequential Organ Failure Assessment score increased from 2.6, 4 days before death, to 2.9, 1 day before death. The increase in these individual Sequential Organ Failure Assessment scores was more prominent in patients who died early (day 0-5). Protein C levels decreased and interleukin-6 levels increased in the days before death.
CONCLUSION: Patients with severe sepsis typically die of multiple organ failure, refractory shock, or respiratory failure. Persistent, more than worsening, organ failure is the more common pattern before death.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21317650     DOI: 10.1097/CCM.0b013e31820eda29

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  48 in total

Review 1.  Year in review 2010: Critical Care--Multiple organ dysfunction and sepsis.

Authors:  Etienne de Montmollin; Djillali Annane
Journal:  Crit Care       Date:  2011-12-05       Impact factor: 9.097

2.  Improving clinical outcomes in sepsis and multiple organ dysfunction through precision medicine.

Authors:  Sanjay Mehta; Sean E Gill
Journal:  J Thorac Dis       Date:  2019-01       Impact factor: 2.895

3.  New or Progressive Multiple Organ Dysfunction Syndrome in Pediatric Severe Sepsis: A Sepsis Phenotype With Higher Morbidity and Mortality.

Authors:  John C Lin; Philip C Spinella; Julie C Fitzgerald; Marisa Tucci; Jenny L Bush; Vinay M Nadkarni; Neal J Thomas; Scott L Weiss
Journal:  Pediatr Crit Care Med       Date:  2017-01       Impact factor: 3.624

4.  Two-way Interaction Effects of Perioperative Complications on 30-Day Mortality in General Surgery.

Authors:  Minjae Kim; Guohua Li
Journal:  World J Surg       Date:  2018-01       Impact factor: 3.352

5.  Reasons for death in patients with sepsis and septic shock.

Authors:  Ari Moskowitz; Yasser Omar; Maureen Chase; Sharukh Lokhandwala; Parth Patel; Lars W Andersen; Michael N Cocchi; Michael W Donnino
Journal:  J Crit Care       Date:  2016-12-02       Impact factor: 3.425

6.  The Epidemiology of Hospital Death Following Pediatric Severe Sepsis: When, Why, and How Children With Sepsis Die.

Authors:  Scott L Weiss; Fran Balamuth; Josey Hensley; Julie C Fitzgerald; Jenny Bush; Vinay M Nadkarni; Neal J Thomas; Mark Hall; Jennifer Muszynski
Journal:  Pediatr Crit Care Med       Date:  2017-09       Impact factor: 3.624

7.  Effects of IgM-enriched immunoglobulin therapy in septic-shock-induced multiple organ failure: pilot study.

Authors:  Ildiko Toth; Andras Mikor; Tamas Leiner; Zsolt Molnar; Lajos Bogar; Tamas Szakmany
Journal:  J Anesth       Date:  2013-01-12       Impact factor: 2.078

Review 8.  Evaluation of vitamin C for adjuvant sepsis therapy.

Authors:  John X Wilson
Journal:  Antioxid Redox Signal       Date:  2013-06-25       Impact factor: 8.401

9.  Enhanced Innate Inflammation Induced by Anti-BTLA Antibody in Dual Insult Model of Hemorrhagic Shock/Sepsis.

Authors:  Tingting Cheng; Jianwen Bai; Chun-Shiang Chung; Yaping Chen; Bethany M Biron; Alfred Ayala
Journal:  Shock       Date:  2016-01       Impact factor: 3.454

10.  Persistent Mitochondrial Dysfunction Linked to Prolonged Organ Dysfunction in Pediatric Sepsis.

Authors:  Scott L Weiss; Donglan Zhang; Jenny Bush; Kathryn Graham; Jonathan Starr; Florin Tuluc; Sarah Henrickson; Todd Kilbaugh; Clifford S Deutschman; Deborah Murdock; Francis X McGowan; Lance Becker; Douglas C Wallace
Journal:  Crit Care Med       Date:  2019-10       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.